David Sinclair of Harvard Medical School and the Sinclair Lab
| | |

David Sinclair and the Battle Over the Future of Aging Science

David Sinclair helped make longevity science impossible to ignore. He also became one of its most contested public figures. Part II examines the criticism, contradictory evidence, and scientific arguments that define the battle over his legacy and the future of aging research.

David Sinclair of Harvard Medical School and the Sinclair Lab
| | |

How David Sinclair Helped Turn Aging Into a Serious Scientific Frontier

David Sinclair helped move aging research from the scientific margins into mainstream conversation. Through his Harvard lab, his work on sirtuins, NAD+ biology, epigenetic reprogramming, and his public role as a translator of longevity science, he helped make aging a serious biomedical frontier.

Illustration of AI-enabled drug repurposing for rare disease treatment discovery
| | |

How Marinka Zitnik Is Teaching AI to Find Hidden Treatments for Rare Diseases

Harvard researcher Marinka Zitnik is building AI systems designed to uncover hidden treatments for rare and neglected diseases. Her TxGNN work points toward a future where drug repurposing becomes more systematic, more transparent, and more useful for patients medicine has historically overlooked.

Scientist in a modern laboratory representing reversing biological aging research breakthroughs 2026
| | |

The Wearable That Rewires Walking: How Cionic’s Neural Sleeve 2 Is Redefining Neurological Mobility

A former Apple and Jawbone engineer built the first FDA-cleared wearable that simultaneously activates muscles and relaxes spasms, giving millions with MS, stroke, cerebral palsy, and spinal cord injuries the ability to walk again. Here is how the Cionic Neural Sleeve 2 works, why the science behind it matters, and what it means for the future of neurological care.